FDA Adverse Event
Malfunction
Summary report: N
TELIGEN
MDR report key: 1944552
·
Received January 3, 2011
Report
- Report Number
- 2124215-2010-19719
- Event Type
- Malfunction
- Date Received
- January 3, 2011
- Date of Event
- August 12, 2010
- Report Date
- October 6, 2010
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
THE AVAILABLE INFORMATION SUGGESTS THAT THIS DEVICE REMAINS IN-SERVICE. THE EVENT WILL BE REOPENED IF ADDITIONAL INFORMATION IS RECEIVED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS PATIENT RECEIVED SHOCK THERAPY. THE CLINIC RN ASKED WHY THE EPISODE WAS NOT DISPLAYED IN LATITUDE. TECHNICAL SERVICES EXPLAINED THAT DEVICE INTERROGATION HAD NOT BEEN PERFORMED POST-SHOCK. BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THE PATIENT RECEIVED INAPPROPRIATE SHOCKS DUE FOR SINUS TACHYCARDIA (ST). TECHNICAL SERVICES EXPLAINED THAT DETECTION ENHANCEMENTS ARE NOT AVAILABLE IF THE ARRHYTHMIA ACCELERATES FROM A VT-1 (MONITOR ONLY) ZONE TO A VT ZONE. TECHNICAL SERVICES DISCUSSED PROGRAMMING OPTIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | E110 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR | (B)(4)| (B)(4)| (B)(4)| (B)(4) |